Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

NCT02805868 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding

Conditions

Myelofibrosis
Polycythemia Vera
Primary Myelofibrosis
Thrombocytopenia

Interventions

PROCEDURE: Bone Marrow Aspiration and Biopsy
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Siltuximab

Sponsor

Northwestern University

Collaborators

[object Object]